Metabolic markers during pregnancy and their association with maternal and newborn weight status.

Obesity during pregnancy increases the risk of adverse clinical outcomes and is associated with low-grade chronic inflammation. We describe maternal metabolic risk and inflammation by maternal weight status, and evaluate the association of metabolic and inflammatory markers with birthweight in a gro...

Full description

Bibliographic Details
Main Authors: Otilia Perichart-Perera, Cinthya Muñoz-Manrique, Angélica Reyes-López, Maricruz Tolentino-Dolores, Salvador Espino Y Sosa, Ma Cristina Ramírez-González
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5531808?pdf=render
id doaj-fb0b5c8138b8461db59db8f514f0541f
record_format Article
spelling doaj-fb0b5c8138b8461db59db8f514f0541f2020-11-24T22:17:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01127e018087410.1371/journal.pone.0180874Metabolic markers during pregnancy and their association with maternal and newborn weight status.Otilia Perichart-PereraCinthya Muñoz-ManriqueAngélica Reyes-LópezMaricruz Tolentino-DoloresSalvador Espino Y SosaMa Cristina Ramírez-GonzálezObesity during pregnancy increases the risk of adverse clinical outcomes and is associated with low-grade chronic inflammation. We describe maternal metabolic risk and inflammation by maternal weight status, and evaluate the association of metabolic and inflammatory markers with birthweight in a group of pregnant Mexican women.This study derived from a prospective cohort of healthy pregnant women <14 weeks of gestation, receiving prenatal care at National Institute of Perinatology (Mexico, 2009-2013). Metabolic and inflammatory markers were measured in maternal serum in all three pregnancy trimesters (1st: 11.42±1.7; 2nd: 21.06±2.4; 3rd: 32.74±2.3 weeks). Pregestational weight was self-reported, and body mass index (BMI) was calculated. Gestational weight gain was evaluated in the third trimester. Newborn´s weight was measured at birth. We carried out correlations, general mixed linear model and regression analyses, based on pregestational weight (self-reported), body mass index (BMI), gestational weight gain (evaluated in the third trimester) and newborn weight (measured at birth).Of the 177 women included in the study (mean age = 26.93±8.49), thirty-eight percent (n = 67) were overweight or had obesity, and 32.8% (n = 58) showed excessive gestational weight gain. We found insulin, lipids (including total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides-TG), leptin and interleukin 1b (IL-1b) all increased significantly (p<0.05) during pregnancy. Pregestational maternal weight status altered longitudinal concentrations of insulin, leptin, adiponectin, TG and C reactive protein. Excessive gestational weight gain was associated with higher maternal insulin in the third trimester (p<0.05). Early pregnancy leptin and TNFα were determinants of birthweight in women with normal weight, but not in overweight or obese women.Maternal weight status affected the concentrations of insulin, leptin, adiponectin, triglycerides and C reactive protein throughout pregnancy. The role of early leptin and TNFα in fetal growth need further study given the association was only observed in normal weight women. This study presents data distribution of metabolic and inflammatory markers of normal weight and overweight/obese women that did not develop GDM, preeclampsia nor macrosomia.http://europepmc.org/articles/PMC5531808?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Otilia Perichart-Perera
Cinthya Muñoz-Manrique
Angélica Reyes-López
Maricruz Tolentino-Dolores
Salvador Espino Y Sosa
Ma Cristina Ramírez-González
spellingShingle Otilia Perichart-Perera
Cinthya Muñoz-Manrique
Angélica Reyes-López
Maricruz Tolentino-Dolores
Salvador Espino Y Sosa
Ma Cristina Ramírez-González
Metabolic markers during pregnancy and their association with maternal and newborn weight status.
PLoS ONE
author_facet Otilia Perichart-Perera
Cinthya Muñoz-Manrique
Angélica Reyes-López
Maricruz Tolentino-Dolores
Salvador Espino Y Sosa
Ma Cristina Ramírez-González
author_sort Otilia Perichart-Perera
title Metabolic markers during pregnancy and their association with maternal and newborn weight status.
title_short Metabolic markers during pregnancy and their association with maternal and newborn weight status.
title_full Metabolic markers during pregnancy and their association with maternal and newborn weight status.
title_fullStr Metabolic markers during pregnancy and their association with maternal and newborn weight status.
title_full_unstemmed Metabolic markers during pregnancy and their association with maternal and newborn weight status.
title_sort metabolic markers during pregnancy and their association with maternal and newborn weight status.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description Obesity during pregnancy increases the risk of adverse clinical outcomes and is associated with low-grade chronic inflammation. We describe maternal metabolic risk and inflammation by maternal weight status, and evaluate the association of metabolic and inflammatory markers with birthweight in a group of pregnant Mexican women.This study derived from a prospective cohort of healthy pregnant women <14 weeks of gestation, receiving prenatal care at National Institute of Perinatology (Mexico, 2009-2013). Metabolic and inflammatory markers were measured in maternal serum in all three pregnancy trimesters (1st: 11.42±1.7; 2nd: 21.06±2.4; 3rd: 32.74±2.3 weeks). Pregestational weight was self-reported, and body mass index (BMI) was calculated. Gestational weight gain was evaluated in the third trimester. Newborn´s weight was measured at birth. We carried out correlations, general mixed linear model and regression analyses, based on pregestational weight (self-reported), body mass index (BMI), gestational weight gain (evaluated in the third trimester) and newborn weight (measured at birth).Of the 177 women included in the study (mean age = 26.93±8.49), thirty-eight percent (n = 67) were overweight or had obesity, and 32.8% (n = 58) showed excessive gestational weight gain. We found insulin, lipids (including total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides-TG), leptin and interleukin 1b (IL-1b) all increased significantly (p<0.05) during pregnancy. Pregestational maternal weight status altered longitudinal concentrations of insulin, leptin, adiponectin, TG and C reactive protein. Excessive gestational weight gain was associated with higher maternal insulin in the third trimester (p<0.05). Early pregnancy leptin and TNFα were determinants of birthweight in women with normal weight, but not in overweight or obese women.Maternal weight status affected the concentrations of insulin, leptin, adiponectin, triglycerides and C reactive protein throughout pregnancy. The role of early leptin and TNFα in fetal growth need further study given the association was only observed in normal weight women. This study presents data distribution of metabolic and inflammatory markers of normal weight and overweight/obese women that did not develop GDM, preeclampsia nor macrosomia.
url http://europepmc.org/articles/PMC5531808?pdf=render
work_keys_str_mv AT otiliaperichartperera metabolicmarkersduringpregnancyandtheirassociationwithmaternalandnewbornweightstatus
AT cinthyamunozmanrique metabolicmarkersduringpregnancyandtheirassociationwithmaternalandnewbornweightstatus
AT angelicareyeslopez metabolicmarkersduringpregnancyandtheirassociationwithmaternalandnewbornweightstatus
AT maricruztolentinodolores metabolicmarkersduringpregnancyandtheirassociationwithmaternalandnewbornweightstatus
AT salvadorespinoysosa metabolicmarkersduringpregnancyandtheirassociationwithmaternalandnewbornweightstatus
AT macristinaramirezgonzalez metabolicmarkersduringpregnancyandtheirassociationwithmaternalandnewbornweightstatus
_version_ 1725785537336311808